DSpace

DSpace at RU >

Browsing by Author Hoffmann, A.L.

Jump to a point in the index:
Or type in a year:
Sort by: In order: Results/Page Authors/Record:
Showing results 1 to 16 of 16
Full TextIssue DateTitleAuthor(s)
2012Differences in radiation dosimetry and anorectal function testing imply that anorectal symptoms may arise from different anatomic substrates.Smeenk, R.J.; Hopman, W.P.M.; Hoffmann, A.L.; Lin, E.N.J.T. van; Kaanders, J.H.A.M.
20123'-Deoxy-3'-18F-Fluorothymidine PET-Derived Proliferative Volume Predicts Overall Survival in High-Grade Glioma PatientsIdema, A.J.S.; Hoffmann, A.L.; Boogaarts, H.D.; Troost, E.G.C.; Wesseling, P., et al
2012Dose-effect relationships for individual pelvic floor muscles and anorectal complaints after prostate radiotherapy.Smeenk, R.J.; Hoffmann, A.L.; Hopman, W.P.M.; Lin, E.N.J.T. van; Kaanders, J.H.A.M.
2012The long-term outcome of patients with polycystic liver disease treated with lanreotide.Chrispijn, M.; Nevens, F.; Gevers, T.J.G.; Vanslembrouck, R.; Oijen, M.G.H. van, et al
2012Individualized dose prescription for hypofractionation in advanced non-small-cell lung cancer radiotherapy: an in silico trial.Hoffmann, A.L.; Troost, E.G.C.; Huizenga, H.; Kaanders, J.H.A.M.; Bussink, J.
2011Neoadjuvant androgen deprivation for prostate volume reduction: the optimal duration in prostate cancer radiotherapyLangenhuijsen, J.F.; van Lin, E.N.; Hoffmann, A.L.; Spitters-Post, I.; Witjes, J.A., et al
2010A practical approach to assess clinical planning tradeoffs in the design of individualized IMRT treatment plans.Monshouwer, R.; Hoffmann, A.L.; Kunze-Busch, M.C.; Bussink, J.; Kaanders, J.H.A.M., et al
201018F-FLT PET/CT for early response monitoring and dose escalation in oropharyngeal tumors.Troost, E.G.C.; Bussink, J.; Hoffmann, A.L.; Boerman, O.C.; Oyen, W.J.G., et al
2009Can FDG-PET assist in radiotherapy target volume definition of metastatic lymph nodes in head-and-neck cancer?Schinagl, D.A.X.; Hoffmann, A.L.; Vogel, W.V.; Dalen, J.A. van; Verstappen, S.M.M., et al
2009Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial.Keimpema, L. van; Nevens, F.; Slembrouck, R. van; Oijen, M.G.H. van; Hoffmann, A.L., et al
2008Convex reformulation of biologically-based multi-criteria intensity-modulated radiation therapy optimization including fractionation effects.Hoffmann, A.L.; Hertog, D. den; Siem, A.Y.; Kaanders, J.H.A.M.; Huizenga, H.
2007A novel iterative method for lesion delineation and volumetric quantification with FDG PET.Dalen, J.A. van; Hoffmann, A.L.; Dicken, V.; Vogel, W.V.; Wiering, B., et al
2007Regarding Davis et al.: Assessment of (18)F PET signals for automatic target volume definition in radiotherapy treatment planning.Hoffmann, A.L.; Dalen, J.A. van; Lee, J.; Gregoire, V.; Oyen, W.J.G., et al
2007Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer.Schinagl, D.A.X.; Vogel, W.V.; Hoffmann, A.L.; Dalen, J.A. van; Oyen, W.J.G., et al
2006IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI.Lin, E.N.J.T. van; Futterer, J.J.; Heijmink, S.W.T.P.J.; Vight, L.P. van der; Hoffmann, A.L., et al
2006Derivative-free generation and interpolation of convex Pareto optimal IMRT plans.Hoffmann, A.L.; Siem, A.Y.; Hertog, D. den; Kaanders, J.H.A.M.; Huizenga, H.
Showing results 1 to 16 of 16

 

  DSpace Software Copyright © 2002-2011  Duraspace - Feedback